Herb ·Insufficient evidence ·Reviewed May 2026
Berry extract traditionally used for prostate and urinary symptoms; larger reviews find mixed-to-negative evidence for BPH symptom relief.
The bottom line
Evidence rating insufficient. Most-documented uses: prostate symptom support (mixed evidence), urinary symptom support (not established). 19 sources indexed (1996–2026), with 11 interaction records on file.
Core mechanism
Saw palmetto extracts may weakly influence androgen and inflammatory pathways in vitro, but clinically meaningful androgen-pathway effects and urinary benefit are not well established.16,12
Take with fat-containing meal10
Dosing protocol
Standardized to 85-95% fatty acids. Effect on BPH symptoms builds over 8-12 weeks.10
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Liposterolic Saw Palmetto Extract.
Assumes 320 mg/day. Vendor basis: NOW/iHerb, Vitacost, Life Extension, and Amazon marketplace; 85-95% fatty acid extracts are mid to premium. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Saw palmetto berries are used medicinally and are not a common food with standardized fatty-acid extract dosing.
What to test, the optimal window inside the conventional range, and how long a response takes.
Saw palmetto (320 mg per day of lipidosterolic extract) shows modest symptom improvement in BPH (IPSS scores); PSA is largely unchanged, unlike 5-alpha reductase inhibitors that lower PSA by about 50 percent.8,9
Track IPSS (International Prostate Symptom Score) and nocturia. Saw palmetto does not interfere with PSA-based prostate cancer screening as much as finasteride/dutasteride do.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Saw palmetto modestly reduces benign prostatic hyperplasia symptoms including nocturia.1,6
Effect builds over 8 to 12 weeks. Rule out other urinary causes.
Saw palmetto may inhibit 5-alpha-reductase and reduce androgen-driven prostate growth, though large trials show mixed and often modest symptom benefit.6,16
Effects are usually small; rising urinary symptoms still need a clinician and a PSA discussion.
In men, saw palmetto is used for prostate-related lower urinary tract symptoms such as frequency and weak stream, but controlled trials have largely failed to show benefit over placebo.5,6
Most relevant only for men with suspected prostate enlargement; have a clinician rule out other causes first, since the best trial data are negative.
Saw palmetto is often tried for prostate symptoms via 5-alpha-reductase and anti-inflammatory effects, but controlled studies in chronic prostatitis / CPPS have generally not shown meaningful benefit.17
More relevant to BPH than to CP/CPPS pain; do not expect it to relieve pelvic pain and keep specialist follow-up.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
Saw Palmetto may partially inhibit 5-alpha-reductase, the enzyme that converts testosterone to DHT, so it is aimed at androgenetic (pattern) hair thinning rather than other causes; the evidence is modest and weaker than prescription options, so treat it as supportive.16,6
Saw Palmetto lipid extracts may modestly support lower urinary tract comfort, possibly through partial inhibition of 5-alpha-reductase and anti-inflammatory effects on prostate tissue. Evidence for benign prostatic hyperplasia is mixed and several rigorous trials found no benefit over placebo, so this is framed as supportive rather than therapeutic.9,5
Saw Palmetto may mildly inhibit 5-alpha-reductase, the enzyme that converts testosterone to the sebum-stimulating androgen DHT, which is the proposed rationale for androgen-related, oily-skin acne. Human acne data are very limited and emerging, and it should be avoided in pregnancy and used cautiously with hormone-sensitive conditions or anticoagulants.16,6
Saw palmetto modestly inhibits 5-alpha reductase and aromatase; DHEA raises downstream androgens. Combined effects on prostate and hormonal milieu can be unpredictable.
Recommendation: If combining, monitor PSA in men and androgenic side effects in women. Discuss with clinician for prostate health context.
Tongkat ali raises testosterone; saw palmetto reduces DHT conversion. Combined effects on prostate-relevant androgens are mixed.
Recommendation: Most men can use both, but track PSA and prostate symptoms in older men. Tongkat ali's testosterone effect is small in eugonadal users.
Both support prostate health through complementary mechanisms; combined use is common in men's BPH protocols.
Recommendation: Standard doses: saw palmetto 320 mg/day plus EPA+DHA 1 to 2 g/day. Effect on prostate symptoms builds over 8 to 12 weeks.
Lycopene and saw palmetto are frequently combined for prostate health, and combination trials suggest complementary benefit for benign prostatic symptoms.
Recommendation: Reasonable to combine for prostate and lower urinary tract support. Take with a meal to aid absorption of fat-soluble lycopene.
Saw palmetto and zinc are a classic prostate-support pairing that target the same hormonal pathway, giving additive support within benign prostatic hyperplasia (BPH) symptom protocols.
Recommendation: Reasonable to combine. Typical doses are saw palmetto 320 mg/day and zinc 15 to 30 mg/day, with copper 1 to 2 mg added on prolonged high-dose zinc to prevent copper depletion.
Saw palmetto and pine bark extract (pycnogenol) are sometimes stacked in men's urinary and prostate formulas, pairing hormonal support with anti-inflammatory and circulatory effects.
Recommendation: Reasonable to combine for prostate and lower urinary tract support. Typical doses are saw palmetto 320 mg/day and pine bark extract 100 to 150 mg/day; allow 8 to 12 weeks for symptom change.
Saw palmetto is often marketed for androgen and prostate symptoms, but clinically meaningful hormone-lowering or BPH symptom benefit is not well established. If used during testosterone therapy, it should be treated as an unproven add-on that may complicate prostate-symptom and PSA discussions.
Recommendation: Do not use saw palmetto as a substitute for evaluating TRT-related prostate, hair, acne, or urinary concerns. Tell your prescriber about use before PSA testing or prostate-symptom monitoring.
Saw palmetto has been linked to coagulopathy and excessive surgical bleeding in case reports, including hematuria and intraoperative hemorrhage. Pharmacokinetic data suggest mild CYP2C9 inhibition, which could slow warfarin metabolism. The signal is modest but clinically relevant given warfarin's narrow therapeutic window.
Recommendation: Avoid saw palmetto while taking warfarin unless your prescriber has approved it. If you take it for prostate symptoms, tell your anticoagulation clinic, keep the dose constant, and ask for an INR check within 1-2 weeks.
Saw palmetto, especially standardized hexanic Serenoa repens extract, has been studied as an add-on to tamsulosin for moderate to severe LUTS/BPH. Combination treatment improved urinary symptom scores more than either treatment alone in observational data, with tolerability similar to tamsulosin. The main practical issue is making sure symptom improvement is monitored while still following prostate cancer screening and BPH follow-up plans.
Recommendation: Use this combination only as an adjunct to your prescribed BPH plan, not as a replacement for tamsulosin. Track urinary symptoms, dizziness, and sexual side effects, and keep routine PSA/prostate follow-up with your clinician.
Saw palmetto (Serenoa repens) has antiandrogenic and 5-alpha-reductase-related activity, overlapping with finasteride therapy for BPH or androgenetic alopecia. A prostate tissue study compared saw palmetto and finasteride effects on prostatic androgens, and a PubMed-indexed case series described persistent sexual and psychiatric symptoms after Serenoa exposure, including combined Serenoa therapies such as finasteride. The concern is additive sexual, mood, or PSA/DHT interpretation effects rather than an acute toxicity syndrome.
Recommendation: Avoid adding saw palmetto to finasteride unless the prescriber knows you are using both. Tell the clinician interpreting PSA, urinary symptoms, hair-loss response, libido, erectile function, mood, or persistent sexual adverse effects if saw palmetto is started or stopped.
Saw palmetto is used for LUTS/BPH and has proposed antiandrogenic activity that overlaps with dutasteride, a dual 5-alpha-reductase inhibitor. PubMed-indexed BPH literature directly compares Serenoa-containing therapy with dutasteride and reviews beta-sitosterol/saw-palmetto pathways, while a recent case series raises concern for persistent sexual and psychiatric symptoms after Serenoa exposure. Co-use may complicate assessment of BPH response, PSA interpretation, sexual adverse effects, and mood symptoms.
Recommendation: Do not add saw palmetto to dutasteride without telling the prescriber. Report changes in libido, erectile function, mood, breast tenderness, urinary symptoms, or PSA monitoring context, especially after starting or stopping saw palmetto.
Numbered references. Citations throughout the page link here.
Schwartzmann I, Redondo A, Farré A et al.. Efficacy and safety of Serenoa repens in benign prostatic disorders: a systematic review of recent clinical evidence. Drugs in context. 2026
Some meta-analyses report improvements in LUTS measures, while higher-quality placebo-controlled reviews have found no clinically important benefit; present as mixed evidence, not established BPH treatment.
Comparative analyses report similar symptom scores in included trials, but this does not overcome the broader mixed placebo-controlled evidence or support an app-level equivalence claim.
Some RCT meta-analyses report nocturia or symptom-score improvements, but results are extract-specific and conflict with negative Cochrane evidence.
Russo GI, Scandura C, Di Mauro M et al.. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials. European urology focus. 2021
Some extract-specific meta-analyses report modest nocturia or urinary-flow improvements, but findings conflict with Cochrane/placebo-controlled evidence and should not be generalized to all saw palmetto products.
Novara G, Giannarini G, Alcaraz A et al.. Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials. European urology focus. 2016
Serenoa repens therapy does not improve LUTS or maximum urinary flow compared with placebo, even at double and triple the usual dose in recent well-designed trials.
Wilt TJ, Ishani A, Stark G et al.. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA. 1998
No evidence for serious toxicity of saw palmetto extract in a well-conducted clinical trial; safety profile comparable to placebo.
Nguyen KT, Verma KK, Matthew E et al.. The Over-The-Counter Finasteride Alternative: A Critical Review of Saw Palmetto's Efficacy, Safety, and Regulatory Concerns. International journal of dermatology. 2026
Mechanistic reviews describe possible 5-alpha-reductase, androgen-receptor, and anti-inflammatory effects, but clinical relevance for symptom improvement remains uncertain.
Adverse events are mild and similar to placebo, including abdominal pain, diarrhea, nausea, fatigue, headache, and decreased libido (rare).
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack